FDA balances speed and safety in drug approvals
Чтение
A new plan wants to make drug reviews faster at the FDA. This plan makes many people worried about important safety decisions.
Faster approvals are making FDA staff feel very stressed and confused. Many leaders have left because of worries about the plan's rules.
FDA scientists usually review drugs carefully for safety and effects. Now, drug approvals seem tied to White House price deals.
Key FDA officials have questioned who can legally approve these drugs. Some leaders have refused to sign off due to legal concerns.
The White House uses this plan to get lower drug prices. Companies also pushed for much faster review times than usual.
Вопросы
What does the new plan aim to do at the FDA?
The new plan wants to make drug reviews faster at the FDA.
Why are FDA staff feeling stressed?
Faster approvals are making FDA staff feel very stressed and confused.
What are some leaders worried about?
Some leaders are worried about the plan's rules and legal concerns.
Опиши изображение статьи
Посмотри на изображение статьи и опиши то, что вы видишь на нём. Можно как печатать, так и говорить голосом.
Обсуждение
Обсуди эту статью со своим ИИ-репетитором для практики. Репетитор поможет с лексикой и грамматикой.
Читайте новую статью каждый день иобсуждайте её с ИИ на lingolette.com